Management team
The management team is responsible for the day to day running of the charity.
Dave Tapolczay
Dave is LifeArc’s CEO. He has 28 years experience in R&D management and has been involved in the start-up of five companies, all of which are still trading.
Message Dave
Edward Bliss
General Counsel and Company Secretary. Edward also manages our Licensing team.
Message Edward
Justin Bryans
Justin runs our drug discovery and antibody engineering groups at the Centre for Therapeutics Discovery who work on small molecule and antibody projects.
Message Justin
Amanda Cowley
As the Head of HR, Amanda is responsible for leading the people agenda within Life Arc.
Message Amanda
Michael Dalrymple
Mike heads up the Centre for Diagnostics Development (CDD), LifeArc’s translational activity seeking to develop novel diagnostic tests from cutting edge basic research. In addition, Mike is leading the creation of a scientific foresighting function at LifeArc to identify future charitable investment areas in translation and runs a small scientific due diligence team that assists the company in new project assessment and acquisition.
Message Michael
Andrew Farquharson
Andrew leads the team responsible for identifying, protecting and progressing promising life science research to improve human health.
Message Andrew
Mike Johnson
Mike leads our Business Development and Marketing teams. He is responsible for accessing projects to fill our drug discovery pipeline, licensing them out to industry partners and creating new models to deliver patient impact.
Message Mike
Andrew Mercieca
Andrew manages our Finance department, and also oversees our ICT service.
Message Andrew
Business Development (BD)
Identifies and acquires projects and seeks commercial partners.
Mike Johnson
Mike leads our Business Development and Marketing teams. He is responsible for accessing projects to fill our drug discovery pipeline, licensing them out to industry partners and creating new models to deliver patient impact.
Message Mike
John Kelly
John heads a team responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.
Message John
David Pardoe
Dave is responsible for creating and implementing novel collaborative models across charity, industry, funder and academic partners that accelerate new therapies to patients.
Message David
Kevin Buchan
Kevin is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.
Message Kevin
Derek Sheader
Derek is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.
Message Derek
Meera Swami
Meera is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.
Message Meera
Zhi Zhang
Zhang is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry, particularly in China.
Message Zhi
Opportunity Assessment Group
Researches and analyses the potential of new and existing biomedical opportunities.
Nicole Mathon
Nicole co-manages the Opportunity Assessment Group which has responsibility for reviewing and assessing new and existing opportunities for LifeArc. The team assesses scientific/technical potential as well as undertaking competitive and market analysis.
Message Nicole
Kerstin Papenfuss
Kerstin co-manages the Opportunity Assessment Group which has responsibility for reviewing and assessing new and existing opportunities for LifeArc. The team assesses scientific/technical potential as well as undertaking competitive and market analysis.
Message Kerstin
Centre for Diagnostics Development (CDD)
Improves commercial readiness of early stage diagnostics from academic research.
Michael Dalrymple
Mike heads up the Centre for Diagnostics Development (CDD), LifeArc’s translational activity seeking to develop novel diagnostic tests from cutting edge basic research. In addition, Mike is leading the creation of a scientific foresighting function at LifeArc to identify future charitable investment areas in translation and runs a small scientific due diligence team that assists the company in new project assessment and acquisition.
Message Michael
Lorraine Anderson
Lorraine heads a team the Centre for Diagnostics Development (CDD), LifeArc’s translational activity seeking to develop novel diagnostic tests from cutting edge basic research.
Message Lorraine
Centre for Therapeutics Discovery (CTD)
Moving early stage molecular targets originating from academic research towards clinical benefit.
Justin Bryans
Justin runs our drug discovery and antibody engineering groups at the Centre for Therapeutics Discovery who work on small molecule and antibody projects.
Message Justin
Katy Kettleborough
Katy is an Associate Director in LifeArc’s Centre for Therapeutics Discovery. She manages a team of biologists carrying out assay development and screening.
Message Katy
David Matthews
David heads up the BioTherapeutics team. The group develops therapeutic antibodies, this includes antibody generation, humanisation, affinity maturation and biophysical characterisation of candidates.
Message David
Andy Merritt
Andy manages a team of medicinal chemists who carry out early stage drug discovery, including hit-to-lead development at our Centre for Therapeutics Discovery.
Message Andy
Technology Transfer (TT)
Identify, protect, develop and license research.
Andrew Farquharson
Andrew leads the team responsible for identifying, protecting and progressing promising life science research to improve human health.
Message Andrew
Mike Bond
Mike covers LMB PNAC (shared), LMB Neurobiology (shared), Gambia, Uganda and CTSU.
Message Mike
Rachael Brooker
Rachael covers LMB PNAC (shared) and IGMM – ECRC.
Message Rachael
Antonia Chatzopoulou
Antonia is responsible for the MRC Institute of Hearing Research, the MRC Cognition & Brain Sciences Unit, the MRC Biostatistics Unit and the MRC Human Nutrition Research unit (shared).
Message Antonia
Georgia Gliki
Georgia covers LMB Cell Biology, LMB PNAC (shared), LMB Neurobiology (shared) and MRC Mitchondrial Biology Unit (shared).
Message Georgia
Sam Goldsmith
Sam covers LMB Neurobiology Division, Mammalian Genetics Unit, Mary Lyons Centre (MRC Harwell).
Message Sam
Karen Law
Karen covers LMB Structural Studies, Human Nutrition Research unit (shared), LMB NMR Facility and MRC Mitochondrial Biology Unit (shared).
Message Karen
Madhu Madhusudhan
Madhu looks after IP issues for our charity partners.
Message Madhu
Anji Miller
Anji manages all IP, contractual and technology transfer matters arising from the MRC Prion Unit.
Message Anji
Steven Tait
Steven covers Institute of Genetics and Molecular Medicine (MMC & HGU) and MRC Clincal Sciences Centre (shared).
Message Steven
Alex Templar
Alex covers LMB Protein and Nucleic Acid Chemistry Division, MRC Molecular Haematology Unit and MRC Human Immunology Units at MRC WIMM.
Message Alex
Governance and Licencing
Negotiate and conclude all commercialisation and other agreements, General legal support for LifeArc business.
Edward Bliss
General Counsel and Company Secretary. Edward also manages our Licensing team.
Message Edward
Marketing & Communications
Coordinates the organisation's marketing and communications.
Jonathan McGee
Jonathan leads our marketing and communications team to enable mutually beneficial relationships between LifeArc and its customers.
Message Jonathan
Liezel Tipper
Liezel manages media relations, internal and external communications.
Message Liezel
Finance
Manages the organisation's long-term and day-to-day monetary operations and strategy.
Andrew Mercieca
Andrew manages our Finance department, and also oversees our ICT service.
Message Andrew
Mimi Ray
For any finance enquiries please contact Mimi Ray at accountsenquiries@lifearc.org
Message Mimi
ICT
The organisation's information technology department plans, operates and supports IT infrastructure.
Paul Clutten
Paul heads ICT team.